CINRYZE subst sèche 500 UI c solv 2 pce
7680616360021
CH-61636
B06AC01
06.01.1.
Reimbursement limitations:
BLUTPRODUKTE
Calcul des prix des préparations sanguines sur la base du prix « ex factory », …
1 / 3
google
Details
- Product number
- 6163601
- CPT
- -
- Packaging group
- -
- Unit
- 2 Fl. à 500 IE/UI Pulver + 2 Fl. à 5 ml Lösungsmittel und Verabreichungsset
- Composition
- Praeparatio cryodesiccata: C1-esterasi inhibitor humanus 500 U.I., natrii citras dihydricus, natrii chloridum, valinum, alaninum, threoninum, saccharum, pro vitro corresp. natrium 11.5 mg. Solvens: aqua ad iniectabile, pro vitro.
Articles (1)
Cinryze 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
500.0 UI | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
11.5 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1337.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2014
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 61636
- Drug name
- Cinryze 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULMI
- ATC Code
- B06AC01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/05/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 06.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CINRYZE subst sèche 500 UI c solv 2 pce
- Description (DE)
- CINRYZE Trockensub 500 IE c Solv 2 Stk
- Market launch
- 23/05/2013
- Narcotic (BTM)
- No